UBS Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $79M | Buy |
670,329
+321,941
| +92% | +$45M | 0.01% | 1226 |
|
|
2025
Q4 | $57.1M | Sell |
348,388
-108,541
| -24% | -$17M | 0.01% | 1479 |
|
|
2025
Q3 | $61.1M | Buy |
456,929
+161,731
| +55% | +$19.6M | 0.01% | 1422 |
|
|
2025
Q2 | $36.7M | Buy |
295,198
+54,124
| +22% | +$6.89M | 0.01% | 1793 |
|
|
2025
Q1 | $30.7M | Buy |
241,074
+52,263
| +28% | +$8.04M | 0.01% | 1936 |
|
|
2024
Q4 | $27.2M | Buy |
188,811
+135,808
| +256% | +$19.5M | 0.01% | 2008 |
|
|
2024
Q3 | $7.89M | Sell |
53,003
-20,894
| -28% | -$3M | ﹤0.01% | 2603 |
|
|
2024
Q2 | $9.32M | Sell |
73,897
-7,851
| -10% | -$1.23M | ﹤0.01% | 2264 |
|
|
2024
Q1 | $15M | Buy |
81,748
+46,917
| +135% | +$8.93M | ﹤0.01% | 1926 |
|
|
2023
Q4 | $6.26M | Buy |
34,831
+5,311
| +18% | +$827K | ﹤0.01% | 2532 |
|
|
2023
Q3 | $4.69M | Sell |
29,520
-60,646
| -67% | -$9.91M | ﹤0.01% | 2636 |
|
|
2023
Q2 | $12.8M | Buy |
90,166
+34,282
| +61% | +$5.5M | ﹤0.01% | 1796 |
|
|
2023
Q1 | $9.41M | Buy |
55,884
+10,101
| +22% | +$1.8M | ﹤0.01% | 1938 |
|
|
2022
Q4 | $7.75M | Buy |
45,783
+17,526
| +62% | +$3.18M | ﹤0.01% | 2107 |
|
|
2022
Q3 | $5.29M | Buy |
28,257
+2,560
| +10% | +$540K | ﹤0.01% | 2301 |
|
|
2022
Q2 | $4.17M | Sell |
25,697
-3,200
| -11% | -$506K | ﹤0.01% | 2523 |
|
|
2022
Q1 | $5.43M | Sell |
28,897
-26,017
| -47% | -$4.94M | ﹤0.01% | 2454 |
|
|
2021
Q4 | $14.5M | Buy |
54,914
+5,866
| +12% | +$1.58M | ﹤0.01% | 1817 |
|
|
2021
Q3 | $14.2M | Buy |
49,048
+8,258
| +20% | +$2.12M | ﹤0.01% | 1771 |
|
|
2021
Q2 | $8.14M | Sell |
40,790
-8,969
| -18% | -$1.74M | ﹤0.01% | 2215 |
|
|
2021
Q1 | $9.67M | Sell |
49,759
-6,837
| -12% | -$1.4M | ﹤0.01% | 1980 |
|
|
2020
Q4 | $10.8M | Buy |
56,596
+1,598
| +3% | +$291K | ﹤0.01% | 1783 |
|
|
2020
Q3 | $8.12M | Buy |
54,998
+22,623
| +70% | +$3.23M | ﹤0.01% | 1793 |
|
|
2020
Q2 | $4M | Sell |
32,375
-9,374
| -22% | -$1.1M | ﹤0.01% | 2225 |
|
|
2020
Q1 | $4.03M | Sell |
41,749
-96,630
| -70% | -$9.33M | ﹤0.01% | 2116 |
|
|
2019
Q4 | $12.8M | Sell |
138,379
-10,312
| -7% | -$866K | ﹤0.01% | 1724 |
|
|
2019
Q3 | $11.4M | Buy |
148,691
+120,004
| +418% | +$10.5M | ﹤0.01% | 1667 |
|
|
2019
Q2 | $2.47M | Sell |
28,687
-15,886
| -36% | -$1.08M | ﹤0.01% | 2960 |
|
|
2019
Q1 | $2.63M | Sell |
44,573
-112,361
| -72% | -$6.46M | ﹤0.01% | 2748 |
|
|
2018
Q4 | $8.28M | Buy |
156,934
+129,049
| +463% | +$7.57M | ﹤0.01% | 1718 |
|
|
2018
Q3 | $1.55M | Buy |
27,885
+125
| +0.5% | +$6.44K | ﹤0.01% | 3451 |
|
|
2018
Q2 | $1.31M | Sell |
27,760
-31,170
| -53% | -$1.28M | ﹤0.01% | 3547 |
|
|
2018
Q1 | $2.13M | Buy |
58,930
+48,051
| +442% | +$1.69M | ﹤0.01% | 3085 |
|
|
2017
Q4 | $395K | Sell |
10,879
-20,625
| -65% | -$747K | ﹤0.01% | 4456 |
|
|
2017
Q3 | $1.21M | Buy |
31,504
+1,179
| +4% | +$49.4K | ﹤0.01% | 3551 |
|
|
2017
Q2 | $1.26M | Buy |
30,325
+18,989
| +168% | +$722K | ﹤0.01% | 3415 |
|
|
2017
Q1 | $399K | Sell |
11,336
-11,282
| -50% | -$357K | ﹤0.01% | 4201 |
|
|
2016
Q4 | $697K | Buy |
22,618
+11,673
| +107% | +$361K | ﹤0.01% | 3866 |
|
|
2016
Q3 | $330K | Sell |
10,945
-225
| -2% | -$6.79K | ﹤0.01% | 4200 |
|
|
2016
Q2 | $305K | Sell |
11,170
-3,145
| -22% | -$80.4K | ﹤0.01% | 4251 |
|
|
2016
Q1 | $384K | Sell |
14,315
-20,574
| -59% | -$503K | ﹤0.01% | 3977 |
|
|
2015
Q4 | $987K | Buy |
34,889
+21,934
| +169% | +$633K | ﹤0.01% | 3418 |
|
|
2015
Q3 | $361K | Buy |
12,955
+1,690
| +15% | +$61.1K | ﹤0.01% | 4167 |
|
|
2015
Q2 | $465K | Buy |
11,265
+2,953
| +36% | +$108K | ﹤0.01% | 4185 |
|
|
2015
Q1 | $252K | Sell |
8,312
-4,955
| -37% | -$129K | ﹤0.01% | 4696 |
|
|
2014
Q4 | $263K | Buy |
+13,267
| New | +$297K | ﹤0.01% | 4779 |
|
Other funds holding RGEN
UCFA
VCM
VPM
MC
UBS Group's RGEN Position: Q1 2026 in Review
UBS Group increased its Repligen (RGEN) stake by 92% in Q1 2026, buying an estimated $45M and bringing the position to 670,329 shares worth $79M. The position accounts for 0.01% of the portfolio, ranked #1226.
UBS Group first reported a position in RGEN in Q4 2014 and has held it in 46 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- UBS Group held 670,329 shares of Repligen worth $79M as of Q1 2026.
- UBS Group bought 321,941 Repligen shares in Q1 2026, an estimated $45M.
- Repligen made up 0.01% of UBS Group's portfolio in Q1 2026, its #1226 holding.
- UBS Group first reported a position in Repligen in Q4 2014 and has held it in 46 quarters since.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.